Search | Aplastic Anemia and MDS International Foundation


Search results

  1. Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome

    ... Purpose:  This will be an open-label, single arm, phase IIa study in subjects with AA or Hypoplastic MDS. ... to IV methylprednisolone dose. The oral dose will be tapered off over 30 days. Other Name: Medrol, Solu-Medrol, Depo-Medrol Drug: ...

    Clinical Trial last updated 04/26/2016 - 11:45am.